, China

China's commercial property investment hits a record $43.8b in 2018

Shanghai and Beijing continued to attract significant foreign investor interest.

Investment into Chinese commercial real estate rose 9.5% YoY to a record-high $43.8b in 2018, according to the latest Greater China Capital Markets Express report by Cushman & Wakefield.

The report highlighted how active foreign capital demonstrated a clear preference for China’s Tier-1 cities in 2018 with investments in these areas amounting to approximately $13.9b (RMB94.6b) even amidst the country’s ongoing crackdown on lending, prevailing trade frictions with the US and a cooling domestic economy. In fact, foreign capital accounted for nearly 99% of total investment in China during the year.

Also read: China's 2019 GDP set to drop further to 6.2%

“Prevailing trade frictions and ongoing economic cooling did little to quench foreign investors’ appetite for property in mainland China,” Catherine Chen, head of forecasting & capital markets research for Greater China at Cushman & Wakefield, said in a statement. “Shanghai was the primary target of foreign capital, recording $10.5b (RMB71.5b) in CRE investment in 2018, surging 78% YoY. Shanghai’s relatively high component of offshore structured assets proved attractive to international investors.”

In Q4 2018 alone, Shanghai’s investment market recorded 22 deals totaling $6.74b (RMB45.18b), an increase of 112% QoQ yet a decline of 10.8% YoY. Singapore’s GIC and CapitaLand’s acquisition of Star Harbour International Centre for $2.95b (RMB19.78b) was regarded as the largest deal in Shanghai in 2018.

“As a result, foreign investors from Singapore outpaced those from Hong Kong and the US by taking up 43.3% of the total foreign investment during the year,” Cushman & Wakefield said. “Shanghai and Beijing will of course remain attractive and should see reasonable transaction volumes in 2019. However, other areas have garnered particular attention of late, the Greater Bay Area being prime amongst there,” Cushman & Wakefield said.

Also read: APAC's commercial real estate investment to rise 5% in 2019

Cushman & Wakefield added that international firms that acquired projects and buildings were observed to favour offshore structures, including embedded lower cost offshore debt which are favourable characteristics when the property comes back for sale.

Meanwhile, the report also highlighted how repurposing for alternative uses saw huge investor interest which ultimately led to a handful of projects closing with this view in mind. Cushman & Wakefield pointed out that successful deals with a clear vision of converting the properties to office use included JD’s acquisition of Beijing Jade Hotel for approximately $296m and China Life’s purchase of Beijing Regal hotel for around $247m.

“Elsewhere in China, key provincial capital cities are also likely to pop up on an increasing number of investors’ radar, including cities such as Nanjing, Hangzhou, Wuhan, Changsha and Chengdu,” the firm added. 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare